Centiva Capital, LP
Institutional investor · Portfolio as of Q3 2025
Top Holdings1,022 positions
ISHARES TR | 4.5M | $1.1B | 10.3% | — | — | — | Increased — |
NVIDIA CORPORATION | 3M | $555.1M | 5.3% | — | — | — | Increased — |
INVESCO QQQ TR | 607,900 | $365M | 3.5% | — | — | — | Increased — |
TESLA INC | 746,100 | $331.8M | 3.2% | — | — | — | Increased — |
ALIBABA GROUP HLDG LTD | 1.8M | $319.9M | 3.1% | — | — | — | Increased — |
ISHARES TR | 3.7M | $300.4M | 2.9% | — | — | — | Decreased — |
ISHARES TR | 3.5M | $282.1M | 2.7% | — | — | — | Increased — |
REGENERON PHARMACEUTICALS | 400,000 | $224.9M | 2.1% | — | — | — | Increased — |
PDD HOLDINGS INC | 1.4M | $184.9M | 1.8% | — | — | — | Increased — |
MICROSOFT CORP | 355,900 | $184.3M | 1.8% | — | — | — | Increased — |
KRANESHARES TRUST | 4.3M | $180.9M | 1.7% | — | — | — | New — |
META PLATFORMS INC | 226,500 | $166.3M | 1.6% | — | — | — | Increased — |
STATE STR SPDR S&P 500 ETF T | 240,800 | $160.4M | 1.5% | — | — | — | Decreased — |
AMAZON COM INC | 700,000 | $153.7M | 1.5% | — | — | — | Increased — |
ALIBABA GROUP HLDG LTD | 845,600 | $151.1M | 1.4% | — | — | — | Increased — |
ELI LILLY & CO | 187,300 | $142.9M | 1.4% | — | — | — | New — |
APPLE INC | 530,000 | $135M | 1.3% | — | — | — | Increased — |
ADVANCED MICRO DEVICES INC | 817,500 | $132.3M | 1.3% | — | — | — | Increased — |
ISHARES TR | 1.2M | $128.7M | 1.2% | — | — | — | Decreased — |
ISHARES TR | 508,100 | $122.9M | 1.2% | — | — | — | Decreased — |
Centiva Capital, LP manages $10.5B across 1022 positions as of Q3 2025. Top holdings: IWM puts (10.3%), NVDA puts (5.3%), QQQ puts (3.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 374 new positions, 912 exits, 109 increased. No standout high-conviction moves this quarter. Portfolio: $10.5B across 1022 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR